Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-43988
Volltext verfügbar? / Dokumentlieferung
Titel: Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis
VerfasserIn: Vukadinović, Davor
Lauder, Lucas
Kandzari, David E.
Bhatt, Deepak L.
Kirtane, Ajay J.
Edelman, Elazer R.
Schmieder, Roland E.
Azizi, Michel
Böhm, Michael
Mahfoud, Felix
Sprache: Englisch
Titel: Circulation
Bandnummer: 150
Heft: 20
Seiten: 1599-1611
Verlag/Plattform: Wolters Kluwer
Erscheinungsjahr: 2024
Freie Schlagwörter: arterial hypertension
meta-analysis
renal denervation
DDC-Sachgruppe: 610 Medizin, Gesundheit
Dokumenttyp: Journalartikel / Zeitschriftenartikel
Abstract: BACKGROUND: Several sham-controlled trials have investigated the efficacy and safety of catheter-based renal denervation (RDN) with mixed outcomes. We aimed to perform a comprehensive meta-analysis of all randomized, sham-controlled trials investigating RDN with first- and second-generation devices in hypertension. METHODS: We searched MEDLINE and the Cochrane Library for eligible trials. Outcomes included both efficacy (24-hour and office systolic [SBP] and diastolic blood pressure [DBP]) and safety (all-cause death, vascular complication, renal artery stenosis >70%, hypertensive crisis) of RDN. We performed a study-level, pairwise, random-effects meta-analysis of the summary data. RESULTS: Ten trials comprising 2478 patients with hypertension while being either off or on treatment were included. Compared with sham, RDN reduced 24-hour and office systolic blood pressure by 4.4 mmHg (95% CI, 2.7 to 6.1; P<0.00001) and 6.6 mmHg (95% CI, 3.6 to 9.7; P<0.0001), respectively. The 24-hour and office diastolic blood pressure paralleled these findings (–2.6 mmHg [95% CI, –3.6 to –1.5]; P<0.00001; –3.5 mmHg [95% CI, –5.4 to –1.6]; P=0.0003). There was no difference in 24-hour and office systolic blood pressure reduction between trials with and without concomitant antihypertensive medication (P for interaction, 0.62 and 0.73, respectively). There was no relevant difference in vascular complications (odds ratio, 1.69 [95% CI, 0.57 to 5.0]; P=0.34), renal artery stenosis (odds ratio, 1.50 [95% CI, 0.06 to 36.97]; P=0.80), hypertensive crisis (odds ratio, 0.65 [95% CI, 0.30 to 1.38]; P=0.26), and all-cause death (odds ratio, 1.76 [95% CI, 0.34 to 9.20]; P=0.50) between RDN and sham groups. Change of renal function based on estimated glomerular filtration rate was comparable between groups (P for interaction, 0.84). There was significant heterogeneity between trials. CONCLUSIONS: RDN safely reduces ambulatory and office systolic blood pressure/diastolic blood pressure versus a sham procedure in the presence and absence of antihypertensive medications.
DOI der Erstveröffentlichung: 10.1161/CIRCULATIONAHA.124.069709
URL der Erstveröffentlichung: https://doi.org/10.1161/CIRCULATIONAHA.124.069709
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-439889
hdl:20.500.11880/39360
http://dx.doi.org/10.22028/D291-43988
ISSN: 1524-4539
0009-7322
Datum des Eintrags: 13-Jan-2025
Bezeichnung des in Beziehung stehenden Objekts: Supplemental Material
In Beziehung stehendes Objekt: https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.124.069709/suppl_file/circ_circulationaha-2024-069709_supp1.pdf
Fakultät: M - Medizinische Fakultät
Fachrichtung: M - Innere Medizin
Professur: M - Prof. Dr. Michael Böhm
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Es gibt keine Dateien zu dieser Ressource.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.